Form 4 for RNAC Cartesian Therapeutics, Inc.
Accepted 2023-01-06 00:00:00 ET · period of report 2023-01-04 · accession 0001453687-23-000035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-01-06 | 2023-01-04+ | RNAC | Brunn Carsten | Pres, CEO, Dir | S - Sale | $1.13 | -41.1K | 786.0K | -5% | -$46.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-05 | S | D | 13,396 | $1.13 | 786,090 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-04 | S | D | 48 | $1.15 | 799,486 | D | — | — | |
| 3 | Common | Common Stock | 2023-01-04 | S | D | 27,549 | $1.13 | 799,534 | D | — | — | |
| 4 | Common | Common Stock | 2023-01-05 | S | D | 77 | $1.12 | 786,013 | D | — | — |